Primary diffuse large B-cell lymphoma of the lacrimal sac

2010 ◽  
Vol 143 (5_suppl) ◽  
pp. 40-40 ◽  
Author(s):  
Alexandria Thomas ◽  
Justin Kong ◽  
Robert Eisenberg
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Jonghyun Kim ◽  
Joohyun Kim ◽  
Sehyun Baek

2016 ◽  
Vol 28 (3) ◽  
pp. 559-563 ◽  
Author(s):  
Hidenori Marunaka ◽  
Yorihisa Orita ◽  
Tomoyasu Tachibana ◽  
Kentaro Miki ◽  
Takuma Makino ◽  
...  

2011 ◽  
Vol 38 (5) ◽  
pp. 643-645 ◽  
Author(s):  
Melis Palamar ◽  
Rasit Midilli ◽  
Nazan Ozsan ◽  
Sait Egrilmez ◽  
Fahri Sahin ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
pp. 42-44 ◽  
Author(s):  
Wei-Shan Tsao ◽  
Tzu-Lun Huang ◽  
Yung-Hsiang Hsu ◽  
Nancy Chen ◽  
Rong-Kung Tsai

2016 ◽  
Vol 2016 ◽  
pp. 1-3
Author(s):  
Kevin Zarrabi ◽  
Ved Desai ◽  
Brandom Yim ◽  
Theodore G. Gabig

We report a rare case of diffuse large B-cell lymphoma (DLBCL) of the lacrimal sac in a 50-year-old male. The incidence of primary ocular lymphoma is low and it is considered a rare disease. Moreover, reports of ocular DLBCL are uncommon and the disease remains poorly characterized. Our patient presented for management of osteomyelitis and was incidentally found to have a painless swelling and cyst around his right eye. A PET/CT scan revealed hypermetabolic activity within the lacrimal sac and a subsequent excisional biopsy of the mass yielded histopathology consistent with DLBCL. Consequently, the patient underwent treatment with R-CHOP therapy. The patient responded well to chemotherapy with a substantial shrinkage in tumor burden and the disease remained localized. Herein, we present a rare case of primary ocular lymphoma, highlight the importance of early diagnosis, and review current treatment modalities.


2010 ◽  
pp. 1351 ◽  
Author(s):  
Toshiyuki Oshitari ◽  
Kajita ◽  
Yotsukura ◽  
Asanagi ◽  
Baba ◽  
...  

2019 ◽  
Vol 9 (3) ◽  
pp. 516-519
Author(s):  
Satoshi Kakutani ◽  
Yasuhiro Takahashi ◽  
Ma. Regina Paula Valencia ◽  
Hirohiko Kakizaki

Purpose: To report a Japanese patient with diffuse large B-cell lymphoma (DLBCL) in the lacrimal sac. Methods: This is a case report of a 52-year-old Japanese woman who presented with a 3-month history of epiphora on the right side and a 1-month history of swelling on the right medial canthal area. Lacrimal sac irrigation showed patency of the lacrimal drainage system. Imaging studies revealed a lacrimal sac mass with involvement of the nasolacrimal duct. Results: Histopathology and immunohistochemistry of the biopsy specimen revealed DLBCL. Systemic workup revealed no other lesion. The patient received 6 cycles of R-CHOP regimen. After completion of the 5th cycle of R-CHOP, all of the symptoms had resolved. Conclusion: We report a case of DLBCL in the lacrimal sac, which is the most common type of lacrimal sac lymphoma in Japan. Since DLBCL is one of the aggressive types of lymphoma, Japanese patients with lacrimal sac lymphoma tend to have a poor prognosis.


Author(s):  
Maria Gabriella Malzone ◽  
Marzio Di Meglio ◽  
Dario Furgiuele ◽  
Nicola Galantuomo ◽  
Sabrina Alfano ◽  
...  

Primary malignant lymphomas of the lacrimal sac are rare neoplasms. They are mainly B-cell lymphoma with nonspecific and atypical symptoms, which can lead to misdiagnosis and a delay in the appropriate cure. Early diagnosis made by biopsy and the right choice of treatments can increase the chance of survival. We report a case of a non-Hodgkin diffuse large B-cell lymphoma (DLBCL) of the lacrimal sac, involving also the drainage system, in a 77-year-old female. She presented with an epiphora, swelling and a heavy visual impairment at the left eye successfully treated with cycles of polychemotherapy and radiotherapy.


2018 ◽  
Vol 29 (6) ◽  
pp. 678-684 ◽  
Author(s):  
Maria Suzanne Sabundayo ◽  
Yasuhiro Takahashi ◽  
Hirohiko Kakizaki

Purpose: To present cases of primary lacrimal sac lymphoma in a Japanese population. Methods: In this retrospective case series, five cases (two males and three females; mean age: 49.8 years; age range: 38–62 years) were included. Clinical features, diagnostic findings, and treatment outcomes were collected and reviewed. Results: Most patients presented with a swelling or mass in the medial canthal area. Only one patient presented with epiphora, while another patient also complained of pain which was due to inflammation. Imaging studies revealed a lacrimal sac mass with involvement of the nasolacrimal duct and variable involvement of the nasal cavity. Histopathological findings revealed three cases of diffuse large B-cell lymphoma, one case of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, and one case of follicular lymphoma. Four cases were treated with a combination of chemotherapy and immunotherapy, with one case necessitating additional radiotherapy. One case was treated with immunotherapy alone. The mean follow-up was 23 (range: 3–50) months. Four cases showed complete remission, while the remaining patient is still ongoing treatment. Conclusion: Diffuse large B-cell lymphoma is the most common type of lacrimal sac lymphoma in this series. Lacrimal sac tumors should be ruled out in the presence of epiphora, dacryocystitis, or a mass in the medial canthus, even in the absence of pain or bleeding. Combined chemotherapy and immunotherapy is an effective treatment for these cases.


Sign in / Sign up

Export Citation Format

Share Document